BackSilence Therapeutics Plc Overview
Silence Therapeutics Plc - ADR

Silence Therapeutics Plc Discounted Cash Flow

DCF Analysis for SLN.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.11

Current Fair Value

$0.11
98.5% Downside

Overvalued by 98.5% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading